The Paris prospective study, a large controlled trial where the independent prognostic role of GH was investigated in the general population, clearly demonstrated that cardiovascular disorders mainly correlate to GH increase rather than to deficiency [37]. Here, GH1 is linked to cardiovascular disorder.